Literature DB >> 25196860

Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.

Dev Prasad1, Harsh Chauhan2, Eman Atef3.   

Abstract

The purpose of this study was to understand the combined effect of two polymers showing drug-polymer interactions on amorphous stabilization and dissolution enhancement of indomethacin (IND) in amorphous ternary solid dispersions. The mechanism responsible for the enhanced stability and dissolution of IND in amorphous ternary systems was studied by exploring the miscibility and intermolecular interactions between IND and polymers through thermal and spectroscopic analysis. Eudragit E100 and PVP K90 at low concentrations (2.5%-40%, w/w) were used to prepare amorphous binary and ternary solid dispersions by solvent evaporation. Stability results showed that amorphous ternary solid dispersions have better stability compared with amorphous binary solid dispersions. The dissolution of IND from the ternary dispersion was substantially higher than the binary dispersions as well as amorphous drug. Melting point depression of physical mixtures reveals that the drug was miscible in both the polymers; however, greater miscibility was observed in ternary physical mixtures. The IR analysis confirmed intermolecular interactions between IND and individual polymers. These interactions were found to be intact in ternary systems. These results suggest that the combination of two polymers showing drug-polymer interaction offers synergistic enhancement in amorphous stability and dissolution in ternary solid dispersions.
© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.

Entities:  

Keywords:  Crystallization Inhibition; Indomethacin; Interaction; Polymer; amorphous; poorly water-soluble drugs; solid dispersion; solubility; supersaturation

Mesh:

Substances:

Year:  2014        PMID: 25196860     DOI: 10.1002/jps.24137

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  13 in total

1.  Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.

Authors:  Shuping Shuai; Shanlan Yue; Qingting Huang; Wei Wang; Junyi Yang; Ke Lan; Liming Ye
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-02-11       Impact factor: 2.441

2.  Effervescence Assisted Fusion Technique to Enhance the Solubility of Drugs.

Authors:  Mohd Aftab Alam; Fahad I Al-Jenoobi; Abdullah M Al-Mohizea; Raisuddin Ali
Journal:  AAPS PharmSciTech       Date:  2015-08-12       Impact factor: 3.246

3.  Sustained-release solid dispersion of pelubiprofen using the blended mixture of aminoclay and pH independent polymers: preparation and in vitro/in vivo characterization.

Authors:  Yeo-Song Lee; Jae Guen Song; Sang Hoon Lee; Hyo-Kyung Han
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

4.  Mechanism-based selection of stabilization strategy for amorphous formulations: Insights into crystallization pathways.

Authors:  Khadijah Edueng; Denny Mahlin; Per Larsson; Christel A S Bergström
Journal:  J Control Release       Date:  2017-04-12       Impact factor: 9.776

Review 5.  The Need for Restructuring the Disordered Science of Amorphous Drug Formulations.

Authors:  Khadijah Edueng; Denny Mahlin; Christel A S Bergström
Journal:  Pharm Res       Date:  2017-05-18       Impact factor: 4.200

6.  A Novel Protocol Using Small-Scale Spray-Drying for the Efficient Screening of Solid Dispersions in Early Drug Development and Formulation, as a Straight Pathway from Screening to Manufacturing Stages.

Authors:  Aymeric Ousset; Rosanna Chirico; Florent Robin; Martin Alexander Schubert; Pascal Somville; Kalliopi Dodou
Journal:  Pharmaceuticals (Basel)       Date:  2018-08-27

7.  Drug crystal growth in ternary amorphous solid dispersions: Effect of surfactants and polymeric matrix-carriers.

Authors:  Afroditi Kapourani; Theodora Tzakri; Vasiliki Valkanioti; Konstantinos N Kontogiannopoulos; Panagiotis Barmpalexis
Journal:  Int J Pharm X       Date:  2021-06-05

8.  Formulation Development, Process Optimization, and In Vitro Characterization of Spray-Dried Lansoprazole Enteric Microparticles.

Authors:  Chintan Vora; Riddhish Patadia; Karan Mittal; Rajashree Mashru
Journal:  Sci Pharm       Date:  2015-07-29

9.  Improved Dissolution and Pharmacokinetics of Abiraterone through KinetiSol® Enabled Amorphous Solid Dispersions.

Authors:  Urvi Gala; Dave Miller; Robert O Williams
Journal:  Pharmaceutics       Date:  2020-04-14       Impact factor: 6.321

10.  Development of a Ternary Solid Dispersion Formulation of LW6 to Improve the In Vivo Activity as a BCRP Inhibitor: Preparation and In Vitro/In Vivo Characterization.

Authors:  Rajiv Bajracharya; Sang Hoon Lee; Jae Geun Song; Minkyoung Kim; Kyeong Lee; Hyo-Kyung Han
Journal:  Pharmaceutics       Date:  2019-05-01       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.